ELI LILLY AND COMPANY |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 930.36 USD | +1.03% |
|
+1.85% | +59.47% |
Main competitors
| 1m. EPS revision | 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Divergence of Estimates | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 25 | |||||||||
| 26 | |||||||||
| 22 | |||||||||
| 27 | |||||||||
| 26 | |||||||||
| 19 | |||||||||
| 20 | |||||||||
| 20 | |||||||||
| 24 | |||||||||
| 22 | |||||||||
| 22 | |||||||||
| 27 | |||||||||
| 21 | |||||||||
| 21 | |||||||||
| 15 | |||||||||
| 16 | |||||||||
| 18 | |||||||||
| 17 | |||||||||
| 15 | |||||||||
| Average | 21 | ||||||||
| Weighted average by Cap. | 23 |
- Stock Market
- Equities
- LLY Stock
- Sector Eli Lilly and Company
- Sector revisions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition